HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoru Yokoyama Selected Research

hirsutine

7/2016Targeting the ataxia telangiectasia mutated pathway for effective therapy against hirsutine-resistant breast cancer cells.
4/2015Selective anticancer activity of hirsutine against HER2‑positive breast cancer cells by inducing DNA damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoru Yokoyama Research Topics

Disease

27Neoplasms (Cancer)
01/2022 - 12/2009
15Melanoma (Melanoma, Malignant)
12/2021 - 01/2006
11Breast Neoplasms (Breast Cancer)
01/2022 - 05/2013
9Neoplasm Metastasis (Metastasis)
11/2020 - 12/2010
6Lung Neoplasms (Lung Cancer)
10/2016 - 12/2009
5Hypoxia (Hypoxemia)
11/2013 - 12/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2016 - 07/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2013 - 06/2012
3Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2013 - 11/2008
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 09/2020
2Clear Cell Sarcoma
10/2011 - 08/2008
1Endometrial Neoplasms (Endometrial Cancer)
01/2022
1Inflammation (Inflammations)
12/2021
1Edema (Dropsy)
04/2021
1Hypertension (High Blood Pressure)
04/2021
1Diabetes Mellitus
04/2021
1Bites and Stings (Sting)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Necrosis
12/2020
1Microcephaly
12/2018
1Autoimmune Diseases (Autoimmune Disease)
06/2018
1Communicable Diseases (Infectious Diseases)
06/2018
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2016
1Obesity
01/2015

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
10/2016 - 12/2005
6LigandsIBA
12/2020 - 05/2013
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2014
5Pharmaceutical PreparationsIBA
01/2020 - 08/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2014 - 01/2012
4Microphthalmia-Associated Transcription FactorIBA
11/2011 - 10/2006
3Monoclonal AntibodiesIBA
01/2022 - 09/2013
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2015
3Indicators and Reagents (Reagents)IBA
11/2020 - 08/2014
3Messenger RNA (mRNA)IBA
07/2009 - 01/2006
2Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 01/2021
2SOXE Transcription FactorsIBA
12/2021 - 10/2006
2Histone Deacetylase InhibitorsIBA
12/2021 - 08/2008
2epidermal growth factor receptor VIIIIBA
01/2021 - 09/2020
2Proteasome Endopeptidase Complex (Proteasome)IBA
11/2020 - 04/2018
2Deubiquitinating EnzymesIBA
11/2020 - 04/2018
2UbiquitinIBA
11/2020 - 04/2018
2Small Interfering RNA (siRNA)IBA
11/2020 - 12/2009
2PhytochemicalsIBA
01/2020 - 04/2015
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 03/2015
2Biological ProductsIBA
12/2018 - 03/2014
2BerberineIBA
07/2017 - 09/2013
2hirsutineIBA
07/2016 - 04/2015
2Phosphotransferases (Kinase)IBA
07/2016 - 07/2015
2Gefitinib (Iressa)FDA Link
01/2016 - 07/2014
2Tyrosine Kinase InhibitorsIBA
01/2016 - 07/2014
2Propolis (Bee Bread)IBA
11/2013 - 07/2013
2chrysinIBA
11/2013 - 07/2013
2Prolyl-Hydroxylase InhibitorsIBA
10/2011 - 11/2008
2heme oxygenase-2IBA
01/2010 - 07/2009
2Heme (Haem)IBA
11/2008 - 12/2005
2Endothelin Receptors (Endothelin Receptor)IBA
10/2006 - 04/2006
1TamoxifenFDA LinkGeneric
01/2022
1Estrogen ReceptorsIBA
01/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1Panitumumab (Vectibix)FDA Link
01/2022
1Interleukin-3 (Interleukin 3)IBA
12/2021
1Interleukin-5 (Interleukin 5)IBA
12/2021
1pregna-4,17-diene-3,16-dione (guggulsterone)IBA
08/2021
1Imiquimod (Aldara)FDA LinkGeneric
04/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1SB 203580IBA
01/2021
1Monounsaturated Fatty AcidsIBA
01/2021
1Firefly LuciferasesIBA
12/2020
1ATP dependent 26S protease (26S proteasome)IBA
11/2020
1VemurafenibIBA
11/2020
1Adenosine Triphosphatases (ATPase)IBA
11/2020
1Tyrosine (L-Tyrosine)FDA Link
09/2020
1flavoneIBA
01/2020
1baicaleinIBA
01/2020
1dinaciclibIBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1InterleukinsIBA
01/2020
1Drug CombinationsIBA
01/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2020
1Carrier Proteins (Binding Protein)IBA
12/2018
1CytokinesIBA
06/2018
1InterferonsIBA
06/2018
1Transcription Factors (Transcription Factor)IBA
04/2018
1Ligases (Synthetase)IBA
04/2018
1COP9 Signalosome ComplexIBA
04/2018
1LuciferasesIBA
04/2017
1Etoposide (VP 16)FDA LinkGeneric
04/2017
1saikosaponin DIBA
04/2017
1Connective Tissue Growth FactorIBA
10/2016
1AlkaloidsIBA
07/2016
1EphA2 ReceptorIBA
07/2015
1tyrosine receptor (receptor, tyrosine)IBA
07/2015
1A-Form DNA (A-DNA)IBA
04/2015
1keishibukuryoganIBA
01/2015

Therapy/Procedure

12Therapeutics
12/2021 - 08/2008
3Drug Therapy (Chemotherapy)
04/2017 - 08/2014
2Traditional Medicine (Folk Remedies)
04/2021 - 12/2013
1Immunotherapy
12/2021
1Kampo Medicine (Kampo)
01/2015